Premium
KALA BIO Inc (KALA)
NASDAQ
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Kala Pharmaceuticals Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapeutics using its proprietary AMPPLIFY Mucus Penetrating Particles, technology, with an initial focus on the treatment of eye diseases. AMPPLIFY particles are selectively-... Kala Pharmaceuticals Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapeutics using its proprietary AMPPLIFY Mucus Penetrating Particles, technology, with an initial focus on the treatment of eye diseases. AMPPLIFY particles are selectively-sized nanoparticles and have proprietary coatings. It has applied the AMPPLIFY technology to create nanosuspensions of loteprednol etabonate, or LE, acorticosteroid designed for ocular applications, resulting in two product candidates. INVELTYS was approved in August 2018 for the treatment of inflammation and pain following ocular surgery and KPI-121 0.25 per cent is in Phase 3 development for the temporary relief of the signs and symptoms of dry eye disease. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.35 | -5.05780346821 | 6.92 | 7.0651 | 6.51 | 18627 | 6.77840932 | CS |
| 4 | -0.29 | -4.22740524781 | 6.86 | 7.9675 | 6.4438 | 19632 | 7.04421104 | CS |
| 12 | -0.82 | -11.0960757781 | 7.39 | 11.2 | 6.39 | 61493 | 8.02485511 | CS |
| 26 | 1.28 | 24.1965973535 | 5.29 | 11.2 | 4.95 | 43103 | 7.53462934 | CS |
| 52 | -1.32 | -16.7300380228 | 7.89 | 11.2 | 4.21 | 80864 | 6.75622103 | CS |
| 156 | -86.93 | -92.9732620321 | 93.5 | 93.5 | 3.5444 | 588669 | 21.30222868 | CS |
| 260 | -347.93 | -98.1466854725 | 354.5 | 734 | 3.5444 | 1013110 | 197.44983048 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
